About this Research Topic
Advanced imaging biomarkers promise to improve the non-invasive characterization, prognostication, and evaluation of treatment response and post-treatment effects related to brain metastases. The imaging biomarkers may aid in the differentiation of metastases from other entities and serve as valuable adjuncts to conventional imaging in distinguishing disease progression from treatment-related effects. The standardization and validation of advanced imaging biomarkers will need to be addressed to facilitate the adoption of such techniques in clinical trials and clinical practice. A survey of the available techniques will help to define more precisely the role of state-of-the-art imaging approaches in targeted problem-solving, as well as their broader utility in elucidating the underlying cancer biology.
This Research Topic will provide a full coverage of current and emerging advanced imaging methods in the care of patients with brain metastases, including diffusion, perfusion, spectroscopy, and functional MRI, positron emission tomography, radiomics and machine learning approaches, to name a few. We will include a comprehensive set of review articles and ground-breaking research articles on the role of advanced imaging markers in the evaluation, management, and treatment of brain metastases.
Keywords: Metastases, Neuroimaging, Magnetic Resonance Imaging, Immunotherapy, Treatment-Related Effect
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.